Here we investigate the roles of the Bone Morphogenetic Protein (BMP) antagonists Chordin and Noggin in development of the mandible, which is derived from the first branchial arch (BA1). Both genes are expressed in the pharynx during early mandibular outgrowth and later in the mandibular process. Mice mutant for either Nog or Chd have only mild mandibular defects; however, pups of the genotype Chd ؊/؊ ;Nog ϩ/Ϫ exhibit a range of mandibular truncation phenotypes, from normal to agnathia. A few embryos homozygous null for both genes survive to late gestation; many are agnathic, though a few have significant mandibular outgrowth. In mandibular explants, ectopic BMP4 rapidly induces expression of both Chd and Nog, consistent with results obtained in vivo with mutant embryos. Previous work has shown that FGF8 is a survival factor for cells populating the mandibular bud. We find that excess BMP4 represses Fgf8 transcription in mandibular explants. Embryos lacking these BMP antagonists often show a strong reduction in Fgf8 expression in the pharyngeal ectoderm, and increased cell death in the mandibular bud. We suggest that the variable mandibular hypoplasia in double mutants involves increased BMP activity downregulating Fgf8 expression in the pharynx, decreasing cell survival during mandibular outgrowth. © 2001 Elsevier Science Key Words: mouse; craniofacial; mandible; BA1; BMP; Noggin; Chordin; Fgf8.
INTRODUCTION
The first branchial arch gives rise to many components of the vertebrate skull, including the jaws, teeth and numerous bones of the skull. In mice, BA1 begins at approximately embryonic day (E) 8.5 as a swelling on either side of the future oral cavity, forming the maxillary and mandibular prominences; these develop into the maxilla and mandible (the upper and lower jaw, respectively). These outgrowths of BA1 grow ventrally towards the midline and fuse at approximately E9.0. Their development is bilaterally symmetric, but the two halves are formed and patterned independently prior to fusion along the midline. Each arch is primarily populated by neural crest (NC) cells originating from the interface of surface and neural ectoderm at the dorsal neural tube (Le Douarain, 1982; Chai et al., 2000) . For proper BA1 development to occur, these cells must properly proliferate and migrate into the branchial arches.
Mandibular development has three major components.
The first is outgrowth, by which the mandibular prominence grows distally from the embryo, as described above. Odontogenesis is the process by which tooth fields are specified and develop into mature dental structures (reviewed in Thesleff and Sharpe, 1997; Jernvall and Thesleff, 2000) . Meanwhile, skeletal development results in formation of the supporting structures of the lower jaw. Expression data and ectopic application of recombinant protein have suggested that BMPs have important roles in all three phases of BA1 development (Neubuser et al., 1997; Bei and Maas, 1998; Dassule and McMahon, 1998; Jernvall et al., 1998; Zhang et al., 2000) . Application of BMP4 protein both in vivo and in vitro results in decreased mandibular outgrowth in the chicken, perhaps as a result of increased cell death (Ekanayake and Hall, 1997; Shigetani et al., 2000) . However, mice mutant for both Bmp5 and Bmp7 show decreased head and branchial arch mesenchyme, also possibly due to cell death (Solloway and Robertson, 1999) . These and other data show that mandibular development is very sensitive to the level of BMP signaling during the initial outgrowth phase. During odontogenesis, BMPs can mimic the inductive properties of the dental epithelium on the underlying mesenchyme (Vainio et al., 1993) and can shape tooth identity in vitro (Tucker et al., 1998) . Several studies implicate BMPs in patterning the skeletal elements of the mandible, in that ectopic BMP will promote growth of ectopic mandibular bones (Barlow and Francis-West, 1997; Wang et al., 1999; Semba et al., 2000) .
The actual requirements for BMPs in mandibular development are unclear. Their roles are obscured both by their requirements in early development (Winnier et al., 1995; Zhang and Bradley, 1996) , and by functional redundancy (e.g., Solloway and Robertson, 1999) . However, BMP2 is required for formation of migratory cranial NC, including that which populates BA1 (Kanzler et al., 2000) . The putative BMP4 targets Msx1 and Msx2 are required for development of teeth as well as other craniofacial structures (Satokata and Maas, 1994; Satokata et al., 2000) . Although the requirements of Msx genes for craniofacial development are consistent with an essential role for BMP signaling, other factors, such as FGFs, also positively regulate Msx1 in facial primordia (Bei and Maas, 1998; Kettunen and Thesleff, 1998) .
Signaling by BMPs is tightly regulated by various downstream effectors and inhibitors as well as by extracellular antagonists (for review see Massague and Chen, 2000) . Two of the known BMP antagonists are Chordin and Noggin. These are structurally unrelated proteins, both of which bind BMPs in the extracellular space to prevent activation of BMP receptors (Piccolo et al., 1996; Zimmerman et al., 1996) . Based on their expression in the Xenopus Spemann's organizer and their activity in embryological assays, Chordin and Noggin were identified as candidate molecules for the neural inductive properties of the organizer (Smith and Harland 1992; Sasai et al., 1994) .
Null mutations in Chordin (Chd) and Noggin (Nog) reveal that they are not required for neural induction, neither individually nor together, although they are essential for many later developmental events (Brunet et al., 1998; McMahon et al., 1998; Bachiller et al., 2000) . A lack of Nog function is lethal at birth and results in profound defects of the skeleton, as well as severe neural tube defects (Brunet et al., 1998; McMahon et al., 1998) . Homozygosity for a Chd null allele is viable with minor defects in the axial skeleton in a random outbred genetic background (D. Bachiller and J. K., unpublished results) . In defined genetic backgrounds, however, Chd nullizygosity is perinatal lethal with defects primarily in branchial arch derivatives (Bachiller et al., 2000; Bachiller et al., unpublished results; R.M.A. and J.K., unpublished results) .
We have begun a genetic analysis of the requirement for the BMP antagonist genes Chd and Nog in craniofacial development. In this study, we confine our analysis to the role of these genes in early mandibular development. We find that although Nog has a unique role in mandibular skeletal morphogenesis, Chd and Nog function in a redundant fashion for mandibular outgrowth. Based on the premise that BMP activity increases when these antagonists are decreased, we have employed a mandibular explant culture system to model the effects of increased BMP activity present in mutant BA1. We use this explant system to probe regulatory interactions involving BMP signaling and test these in vitro findings in the mouse mutants. We find that BMPs are capable of affecting the transcription of FGF8 targets, Fgf8 itself, and, surprisingly, of BMP antagonists. Based on our analysis of Chd;Nog double mutants, we suggest that mandibular development requires proper modulation of BMP activity, and that mandibular hypoplasia in the mutants involves variable downregulation of Fgf8 expression. Bachiller et al. (2000) . Chordin mutant mice are maintained in a 129Sv inbred background. Wild type embryos for explant culture were obtained from timed matings of ICR mice; a copulation plug at noon was noted as embryonic day 0.5.
MATERIALS AND METHODS

Embryo Collection
Organ Culture and Bead Implantation
Mandibular cultures were prepared as described (Vainio et al., 1993) with some modifications (a detailed protocol is available on request). Explants were usually cultured with the oral side on membrane culture inserts (Whatman) with beads on the aboral surface. Beads were prepared as described (Vainio et al., 1993) . Recombinant BMP4 was obtained from Genetics Institute (Cambridge, MA; 80 ng/l on Affigel beads). Control beads were treated with PBS or 0.1% BSA in protein storage buffer. Culture medium used is DMEM (Gibco), 10mM nonessential amino acids (Gibco), 0.1 mM ␤-mercaptoethanol (Gibco), Pen-Strep, and 15% FCS (HyClone). Explants classified as E10.5 were taken from embryos at 30 -35 somites. E11.5 embryos were at 35-40 somites.
In Situ Hybridization and Probes
Whole mount in situ hybridization was similar to that of Belo et al. (1997) . All probes used in this study are published: AP2␣ (Mitchell et al., 1991) , Bmp4 (Winnier et al., 1995) , Chordin (Klingensmith et al., 1999) , Fgf8 (Crossley and Martin, 1995) , Msx1 (Mackenzie et al., 1991) , Noggin , and Pax9 (Neubuser et al., 1995) .
RT-PCR
Chordin expression was documented using total RNA from stage-appropriate embryos isolated using standard RNA purification techniques (Stratagene total RNA isolation kit). Total RNA was used for in vitro cDNA synthesis with MMLV reverse transcriptase (MMLV-RT; Gibco). HPRT was amplified as a control for successful cDNA preparation using 35 PCR cycles with the following primers: (CCTGCTGGATTACATTAAAGCACTG) and (GT-CAAGGGCATATCCAACAACAAAC). Chd was amplified with ChdRT1 (CCAGAGCATCGCAGTTACAG) and ChdRT2 (TGT-GGGATCTGTGAAACGAA).
Cell Death, Proliferation, and Histology
Cell death was detected as described; briefly, in whole embryos by staining with nile blue sulfate (Sigma N-5632; Bowen and Lockshin, 1981) or in sectioned material by TUNEL (Roche; manufacturer's protocol). Proliferation was assayed in sections by labeling with anti-phosphohistone H3 (Upstate Biochemicals) as described (Hentges et al., 1999) . To determine the expression of noggin in sectioned material, embryos heterozygous for the nogginLacZ allele were cryo-sectioned and stained with X-gal using standard methods (Hogan et al., 1994) .
RESULTS
BMP Antagonists Are Expressed in the Developing First Branchial Arch
To begin determining a potential role for BMP antagonists in mandibular development, we have studied the expression of noggin and chordin in early BA1 development. Of interest were expression domains in the mandibular prominence itself, in the NC that migrates into the arch, and in the pharynx, through which the NC cells migrate enroute to the bud. Noggin expression was analyzed both by ␤-galactosidase staining of embryos carrying a lacZ integration in the Nog locus (see Materials and Methods) and by whole mount in situ hybridization (WMISH). Nog-lacZ embryos show expression in the mesenchyme of the initial swelling of BA1 (E8.5; Fig. 1A ) in a pattern suggestive of migrating NC, which populates the mesenchyme of BA1 (e.g., Chai et al., 2000) . Noggin has previously been shown to be expressed in chicken migrating NC cells (Smith and Graham, 2001) . Noggin is expressed in the mesendoderm derived from the node through at least E8.5, including the roof of the pharynx (R.M.A., unpublished results). As the mandibular prominence extends during E9.0 -9.5, expression is also seen in the pharyngeal/caudal mandibular ectoderm (Fig. 1B) . These expression domains are recapitulated with WMISH of E9.5 embryos (Fig. 1C) . At E10.5 (Fig. 1D ) and E11.5 (Fig. 1F) , Nog expression is seen by WMISH in the oral epithelium of the mandible. Sense riboprobe controls show no epithelial signal (Fig. 1E) . ␤-galactosidase staining of cryo-sectioned Nog ϩ/Ϫ embryos at E10.5 (Fig. 1G) confirm this low-level ectodermal expression. Cryo-sections also show a domain of high expression in the deep mesenchyme, possibly in precursors of Meckel's cartilage (Fig. 1H) , which is derived from NC cells. Nog expression in Meckel's cartilage is high at later stages (data not shown). Although Nog is expressed in the NC emigrating to BA1, it is not clear if the expression in Meckel's cartilage is a direct continuation of NC expression or a separate inductive event. Mesenchymal expression is, however, distinct from the epithelial expression seen at later stages as the epithelium and mesenchyme do not exhibit significant mixing during BA1 development (Chai et al., 2000) . Our analysis focused on expression in the mandibular prominence, but we also noted expression in the maxillary prominence (data not shown).
Other work has demonstrated weak Chd expression in the branchial arches at E10.5 and E11.5, assayed by section in situ hybridization using radioactive probes (Scott et al., 2000) . Expression appeared to occur at low levels throughout the arch. To further define when and where Chd is expressed, especially relative to Nog, we used digoxigeninlabeled riboprobes in WMISH experiments. At E8.5, as the mandibular bud emerges, a low-level of expression was observed in the pharyngeal and mandibular bud ectoderm, and in the forming pharyngeal cleft ( Fig. 2A) . At this time, Chd is also expressed in the roof of the foregut, that is, in dorsal pharyngeal endoderm (R.M.A., unpublished results). At E9.0 weak pharyngeal ectoderm expression was observed, with probable weak expression in the pharyngeal endoderm as well (Fig. 2B) . We also observe low-level Chd expression in BA1 at E10.5 (Fig. 2E,F ) and E11.5 (Fig. 2G,H) . Expression at E9.5 is much less distinct (Fig. 2C,D) . Expression in mandibular processes appears to be predominantly ectodermal (data not shown). Because none of these domains of Chd expression was strong as visualized by WMISH, we performed RT-PCR analysis to assess independently the expression of Chd in these tissues. We detected Chd expression at each stage of BA1 development examined: in E8.5 pharyngeal tissue and in mandibular processes at E9.5-E11.5 (Fig. 2I) .
These results indicate that both Noggin and Chordin are expressed such that they might have a role in the three major phases of BA1 development. Their expression in and around the pharynx as the mandibular bud emerges would be consistent with a role in outgrowth. Later expression in the mandibular ectoderm through at least E11.5 could enable them to function during early odontogenesis (Thesleff and Sharpe, 1997) . Noggin at least seems also to be potentially involved in early skeletogenesis, based on its expression in Meckle's cartilage. Because Chordin and Noggin appear to act exclusively by antagonizing BMPs such that BMP signal transduction is precluded (Harland and Gerhart, 1997) , these expression domains of Chd and Nog would be relevant only if BMPs were expressed nearby. Indeed, those BMPs known to be antagonized by Chordin and Noggin (BMP2, 4 and 7) are each expressed during all three phases of BA1 development in tissues overlapping or near Chd and Nog expression (Begbie et al., 1999; Jones et al., 1991; Kanzler et al., 2000; Lyons et al., 1990; Solloway and Robertson, 1999) . BmprIA, encoding a receptor for BMP2, BMP4, and perhaps other family members (Massague and Chen, 2000) , is expressed ubiquitously throughout the embryo at these stages (DeWulf et al., 1995; Panchison et al., 2001 ).
Loss of Either Noggin or Chordin Has Mild Effects on Mandibular Development
We have analyzed mice homozygous null for either Chd or Nog for defects in mandibular development. The overall phenotype of both mutations depends on the genetic background in which the null allele is carried. We examined Nog Ϫ/Ϫ mutants in a highly polymorphic, outbred background and in two inbred backgrounds, C57bl6 and 129Sv. The phenotypes at birth are very similar in each case; however, the craniofacial phenotype is more severe in the 129Sv background, which is presented here. When compared at birth to wild-type 129Sv mice (Fig. 3A,D) , Nog Ϫ/Ϫ littermates ( Fig. 3B,E) have an incompletely penetrant phenotype of micrognathia, among other more drastic defects of skull development. All mutant mice in each genetic background observed, however, exhibit a mildly malformed mandible characterized by increased bone thickness (Fig.  3E,K) . C57bl6 Nog Ϫ/Ϫ mutants were not analyzed for outgrowth phenotypes as they have a variably penetrant reduction in total head size.
In an inbred 129Sv background, mice homozygous null for Chd are born dead and have a variety of facial defects, externally characterized by a reduced distance between the eye and pinna (Fig. 3C ). Defective skeletal elements include BA1 derivatives such as the zygomatic and temporal bones, as well as bones of the chondrocranium (data not shown). A similar phenotype is observed in a defined hybrid background, and we present a mechanistic analysis of these and
FIG. 1. Expression of noggin in the developing first branchial arch. The expression of Nog was determined using both a LacZ insertion (A, B, G, H) as well as whole mount in situ hybridization of isolated BA1 (first branchial arch) with Nog probe (C, D, F).
Nog-lacZ expression faithfully represents the spatiotemporal pattern of Nog transcription . X-gal staining at E8.5 (A) and E9.5 (B) shows expression of Nog in a punctate pattern suggestive of migrating NC cells, which populate the mesenchyme of BA1 (Trainor and Tam, 1995; Imai et al., 1996) . This is also seen in WMISH (C). Expression of Nog-lacZ is also indicated at the dorsal neural tube in a rhombomere-specific pattern where these NC cells are initiating (arrowheads in B). At E10.5 (D, E, G) and E11.5 (F, H), Nog expression is seen at low levels in the oral epithelium. Sense controls (E) show no expression. Sagittal cryosections at E10.5 (G) and E11.5 (H) show individual cells (arrows) expressing the Nog-lacZ reporter in the oral epithelium. At E10.5, expression is also seen in Meckel's cartilage (MC; black arrow).
FIG. 2.
Expression of chordin in the developing first branchial arch. Expression of chordin by WMISH is seen at E8.5 (A) in the pharyngeal endoderm (arrow). At E9.0 (B), expression is seen in both pharyngeal endoderm and ectoderm. At E9.5 (C), low levels of Chd expression are seen in BA1 and become stronger at E10.5 (E) and E11.5 (G). Sense riboprobe controls at each age (D, F, H) show no appreciable signal. Chd expression was also addressed using RT-PCR (I), since in situ expression was weak. Pharyngeal regions of E8.5 embryos (ln. 2) as well as branchial arches from E9.5 (ln. 3), E10.5 (ln. 7) and E11.5 (ln. 8) show Chd transcripts. Other embryonic regions with low levels of Chd expression as assayed by WMISH, such as the allantois (data not shown), show Chd expression with RT-PCR (ln. 4). Control reverse transcription reactions of blank samples (ln. 5), without MMLV-RT (ln. 6), and water PCR controls (ln. 9) show no PCR products. (a: allantois, h: heart, mbl: left midbrain, mbr: right midbrain, ov: optic vesicle, p: pharynx)
other Chd Ϫ/Ϫ phenotypes elsewhere (D. Bachiller, R.M.A, J.K, unpublished results). However, in all cases to date, regardless of genetic background, Chd Ϫ/Ϫ pups have overtly normal mandibles (Fig. 3F,I ,L). Although the mutant mandibles occasionally appeared to be smaller than those from their wildtype littermates, this seemed to be part of a modest microcephaly phenotype, in which all skeletal elements of the head were often slightly smaller than in wildtype (data not shown).
Our analysis makes clear that the BMP antagonists Chordin and Noggin are individually necessary for normal development of BA1 derivatives. However, despite expression in the oral epithelium, we detected no mandibular defects in the absence of Chd. The thickened mandible phenotype of Nog Ϫ/Ϫ pups is consistent with previously observed skeletal defects in other bones of Nog Ϫ/Ϫ mutants (Brunet et al., 1998) , and thus may reflect a more general role for Noggin in skeletal development. Mechanistic analysis of the mandible skeletal dysmorphology is beyond the scope of this paper.
Although BMPs have been implicated in proper tooth patterning and development (Tucker et al., 1998) , a preliminary analysis revealed no significant tooth phenotype in either Chd or Nog homozygotes. Skeletal preparations clearly show the presence of incisors and alveolar ridges (site of molar development) in both classes of mutants . Because Nog mutants display a mandibular phenotype, we cryo-sectioned mandibles of Nog Ϫ/Ϫ mutants at both P0 and E14 to address early tooth development. We found that both maxillary and mandibular molars are present at birth and seem to be patterned correctly (data not shown).
Chd;Nog Double Mutants Have a Spectrum of Mandibular Hypoplasia
Chordin and Noggin are coexpressed in the mandibular prominence and are dedicated antagonists of the same BMPs (Harland and Gerhart, 1997) , and homozygotes for null alleles of either gene exhibit only mild mandibular phenotypes at worst. To test the possibility of functional redundancy in mandibular development, we generated double mutants lacking both Chd and Nog. This genotype (Chd Ϫ/Ϫ ;Nog Ϫ/Ϫ ) is hereafter referred to as the double null mutant. Double mutants were generated in an outbred genetic background, since mandibular phenotypes do not change as a result of genetic background (see above). This allowed us to exploit the increased fecundity of outbred mice and the viability of Chd homozygosity in an outbred background, thus making the production of double mutants much more efficient.
While generating the double null mutants, we observed a severe mandibular phenotype in mice lacking both copies of Chd and one copy of Nog (Chd Ϫ/Ϫ ;Nog ϩ/Ϫ ). We will refer to this genotype as the complex heterozygote. We found that about 10% of complex heterozygotes display conspicuous anterior tissue deficits but no apparent phenotypes posterior to the neck; many of these displayed jaw truncations that occurred independently of more rostral defects (R.M.A., unpublished results). We found an overall frequency of mandibular truncations of about 9% in complex heterozygotes, but did not observe such defects in Chd or Nog hetero-or homozygotes (Table 1) . We analyzed these perinatal-lethal complex heterozygote pups for mandibular defects, observing a variety of phenotypes ranging from normal ( Fig. 4A,B ) to mild micrognathia (Fig. 4C,D ) and occasional agnathia (Fig. 4 E,F) . Additionally, some mutants show mandibular defects that are bilaterally asymmetric; for example, resulting in one normal half-mandible and one completely absent (Fig. 4G,H) . In the example shown here, the unaffected side even has an incisor indicating proper mandibular patterning all the way to the distal extremities. While some complex heterozygotes show abnormal odontogenesis, these defects result from loss of distal mandibular tissue rather than specific problems in tooth patterning. In complex heterozygotes having overtly normal mandibles, regardless of the severity of more rostral defects, we did not observe tooth defects (data not shown).
Double null mutants (Chd Ϫ/Ϫ ;Nog Ϫ/Ϫ ) show defective patterning of the anterior-posterior, dorsal-ventral and leftright axes, but rarely survive past E10.5 (Bachiller et al., 2000) . Our initial analysis showed that those Chd Ϫ/Ϫ ;Nog Ϫ/Ϫ embryos surviving through branchial arch stages exhibit agnathia (Bachiller et al., 2000) . These double mutants were analyzed in a mixed hybrid genetic background; the double null mutants studied here are in an outbred background, but display defects in all three axes indistinguishable from those of the mixed hybrid background (R.M.A. and J.K., unpublished results). However, at least in the outbred background, there is a range of mandibular phenotypes in the double null mutant. In some cases, despite severe rostral defects, BA1 formation is surprisingly normal despite the complete absence of Chd and Nog (Fig. 4J) . Other embryos displaying similar anterior defects show greatly reduced BA1tissues (Fig. 4K) ; these presumably would reflect the agnathic embryos that occasionally survive to late gestation.
In sum, our analysis of Chd;Nog complex heterozygotes and double null mutants revealed a range of mandibular phenotypes within both genotypic classes. All of the phenotypes described above in the two classes of double mutant appear to be due to defects in mandibular outgrowth, since they are detectable well before the onset of skeletogenesis. The severity of the mandibular deficit is typically greater in the double mutant than in the complex heterozygote, though either genotype can display mildly micrognathic through agnathic phenotypes. These results indicate a partial functional redundancy between the BMP antagonists Chordin and Noggin in BA1 development. The phenotypic variability also indicates mandibular development is variably sensitive to the levels of BMP antagonists and, presumably, of BMP activity.
An Explant System to Assay the Effects of Increased BMP Signaling in the Developing Mandibular Prominence
Mechanistic analysis of the BA1 defects in Chd;Nog mutants proves very difficult because complex heterozygote mandibular phenotypes are rare and vary in severity (i.e., exhibit low penetrance and variable expressivity), and the double null embryos usually die by E10.5. Due to the Note. Animals of each genotype were observed for defects in mandibular outgrowth. Skeletal preparations of P0 pups were examined after processing and adults were observed during husbandry. Double homozygosity is lethal at midgestation, preventing analysis of perinatal jaw phenotypes.
biochemical function of Chordin and Noggin, we suspect the defects described above are the result of an overactive BMP signaling cascade. To more fully explore the possible effects of enhanced BMP signaling in the mandibular arch, we have employed a well-established mandibular explant system (reviewed by Slavkin et al., 2000) . In this technique (Fig. 5A) , recombinant proteins can be applied to the explants and molecular consequences analyzed through in situ hybridization.
We have chosen to culture mandibular portions of BA1 explants and applied a bead incubated in recombinant protein or in control carrier buffer on one side of the explant, that is on one "half-arch," (see Fig. 5A ). While gene expression domains may shift slightly in some explants from in vivo due to flattening of the explanted tissue during culture, it remains very obvious when the BMP beads have affected a molecular change. Culturing the explants without splitting them in half, a common manipulation used in mandibular culture, gives us an internal control after visualizing gene expression: the control side of each explant should indicate endogenous gene expression and be used as a comparison to treated tissue.
To mimic the increased BMP signaling that may be occurring in the various Chd and Nog mutant embryos, we have added sepharose beads treated with recombinant BMP4 protein to the explant epithelium. These beads should act to increase the level of activation of the BMP signal transduction pathway in the epithelium. We have assayed the effects of recombinant protein by using whole mount in situ hybridization to reveal the expression of possible BMP targets (see Table 2 and representative examples shown in Fig. 5B-J) . As previously demonstrated (Vainio et al., 1993) , ectopic BMP4 induces the putative target transcription factor, Msx1 (Fig. 5B) . Similarly, as shown before (Neubuser et al., 1997) , ectopic BMP4 inhibits the transcription of the putative Fgf8 target, Pax9 (Fig. 5E) . These experiments confirm that this mandibular explant system can be used to model what may be occurring in mandibular prominences with reduced levels of BMP antagonism, as is presumably the case in Chd;Nog mutants.
Ectopic BMP4 Represses Fgf8 Expression in Mouse Mandibular Cultures
Two separate pieces of evidence led us to test for effects of increased BMP4 on the expression of Fgf8 itself. First, the phenotypes we observe in the complex heterozygote are similar in severe cases to the phenotypes of mouse embryos specifically lacking Fgf8 expression in BA1 (i.e., agnathia; Trumpp et al., 1999) . Moreover, the BMP and FGF signaling pathways are known to interact antagonistically in many developmental contexts, including development of branchial arches, where they act to restrict the expression of Pax9, Pitx2, and Barx1 to precise locations on the proximal-distal axis of the branchial arch (Neubuser et al., 1997; Barlow et al., 1999; St. Amand et al., 2000) . We observe that ectopic BMP4 inhibits transcription of Fgf8 (Fig. 5H ) in addition to the Fgf8 target gene Pax9 (Fig. 5E ) in mouse mandibular cultures ( Table  2 ). The effects of ectopic BMP4 were replicable independent of bead position on the explant in the medial-lateral or anterioposterior axes (data not shown).
Ectopic BMP4 Induces the Expression of Its Own Antagonists in BA1 Cultures
Previous experiments in cell culture models (Gazzerro et al., 1998; Kameda et al., 1999; Nifuji and Noda, 1999) and in chicken limb digits (Merino et al., 1998) suggest that Nog may be directly regulated by BMP4. We find this is also true in our culture system (Table 2) ; ectopic BMP4 induced the expression of Nog (Fig. 5D) . We find that BMP4 can also induce the expression of Chd in mandibular explants (Table  2 ), albeit at relatively low levels (Fig. 5G ). This induction is more robust in explants prepared from E11.5 embryos (Fig. 5J) .
Noggin Is Induced Rapidly Upon Increased BMP4 Signaling, While Fgf8 Repression Is Slower
To further address the mechanism of Fgf8 repression and Nog induction, we looked at the effects of ectopic BMP4 at 1, 3, and 6 h of culture (see Table 3 ). We find that Msx1 and Nog are both induced within 1 h of BMP4 application (Fig.  6 A,C) . Fgf8 expression does not appear to be reduced until 3 h of BMP4 co-culture (Fig. 6F) . These data indicate that increased BMP activity rapidly induces its own antagonist, probably via molecular mechanisms already present in the cell rather than by increased transcription of BMP effectors such as Msx1. In contrast, Fgf8 repression may be less direct.
Mice Lacking BMP Antagonist Genes Exhibit Elevated BMP Signaling and Reduced Fgf8 Expression
Results from the mandibular explant assays suggest that some molecules known to be involved in patterning BA1 may be misexpressed in mice lacking proper BMP antagonism. Specifically, one might expect expanded expression domains of genes induced by BMP4, and smaller domains for genes induced by Fgf8. Our explant analysis revealed the ability of BMP4 to induce Nog, so we assessed Nog Ϫ/Ϫ embryos for expression of the Nog-lacZ reporter. Nog Ϫ/Ϫ embryos expressed much higher levels of lacZ than did heterozygous littermates, and Chd Ϫ/Ϫ ;Nog Ϫ/Ϫ embryos expressed Nog-lacZ at even higher levels (compare Fig. 7A , B, and C). This increase in Nog-lacZ expression was broadly present, including BA1 (compare Fig. 7D and E) . Increased levels of Nog-lacZ expression are not simply due to lacZ copy number, because WMISH at E9.5 also shows increased expression in Nog Ϫ/Ϫ embryos (Fig. 7G ) compared to unaffected littermates (Fig. 7F) , especially in the neural tube. Expression of Nog in the NC at this stage is also increased in the Nog Ϫ/Ϫ embryos (Fig. 7B,C) . Assuming that more BMP activity results from the loss of these BMP antagonists, our results would imply that BMPs induce their own antagonists in vivo as well as in vitro. Consistent with results showing the ability of BMP4 to induce its own expression in the dental mesenchyme and other tissues (Vainio et al., 1993; McMahon et al., 1998) , the expression of Bmp4 is slightly increased in BA1 of Nog Ϫ/Ϫ embryos when compared to unaffected littermates ( Fig. 7H,I ; 2:2). The signal appears both stronger and slightly expanded in mutants.
The role of Fgf8 in BA1 development has been revealed by recent data from a branchial arch specific knockout (Trumpp et al., 1999) . Mandibles in these mice showed a range of phenotypes similar to those seen in our mutants. Since we observed that surplus BMP4 represses Fgf8 expression in mandibular explants, we speculated that the affected Chd;Nog mutants might exhibit reduced Fgf8, whereas unaffected embryos of the same genotype would not. Because BMP can upregulate its own antagonists and because mice mutant for either BMP antagonist have only minor defects in mandibular development, we expected at most a subtle downregulation of Fgf8 in BA1 of single mutants. Indeed, WMISH of Nog Ϫ/Ϫ mice at E10.5 shows little if any decrease in Fgf8 expression in branchial arches relative to nonaffected littermates ( Fig. 7J,K ; 4:4). In contrast, Chd;Nog double null embryos show an incompletely penetrant reduction in BA1 expression of Fgf8 (e.g., Fig. 7 O,P). This variability in Fgf8 expression may correspond to the variable mandibular truncations of the complex heterozygotes and double null mutants. Indeed, as with the pups showing bilaterally asymmetric defects in mandibular skeletal development (Fig. 4G,H) , in some cases, the level of repression in a single double null mutant embryo is not identical between the bilateral swellings of the developing BA1 ( Fig. 7O,P) .
One possibility for the lack of elongation seen in mutant BA1 is a deficit in NC cells themselves. We have observed several different markers of NC cells at various stages in Chd;Nog mutants ( Fig. 7L,M 
; R.M.A. unpublished results).
We have never detected a defect in NC specification, migration or patterning.
Branchial Arch Cell Death in Embryos Lacking BMP Antagonist Genes
If Fgf8 signaling is decreased in Chd;Nog mutants, the loss of this growth factor should create increased rates of cell death and decreased rates of cell proliferation. We examined cell death by nile blue sulfate (NBS) staining in Chd;Nog double null and complex heterozygous mutants. At E8.5, prior to bud outgrowth, few NBS-positive cells are detected in the first arch of either wildtype or mutant embryos (data not shown). Although the amount of cell death in the core mesenchyme of the first branchial arch remains low in wildtype embryos at E9.5 (Fig. 8A) , cell death is greatly increased in this region in double null embryos (Fig. 8B-D) . Variability in the level of cell death
FIG. 4. Complex heterozgotes (Chd
Ϫ/Ϫ ; Nog ϩ/Ϫ ) and double null homozygotes (Chd Ϫ/Ϫ ; Nog Ϫ/Ϫ ) exhibit a range of craniofacial phenotypes. Heads of pups (A, C, E, and G) and corresponding skulls (B, D, F, and H) are shown, all of which are the same complex heterozygote genotype. Phenotypes range from overtly normal (A, B) through mild micrognathia (C, D) to almost complete agnathia (E, F); note the rudimentary mandible in F (small arrow). In the example shown in panels G and H, the result is a mandible which looks normal on one side but is completely absent on the other; note the incisor on the unaffected half of the mandible (arrowhead in H). We also found a spectrum of more anterior truncations, which will be described elsewhere (R. M. A., unpublished results). Embryos homozygous null for both chordin and noggin already show a range of phenotypes at early stages of BA1 development (E9.5 shown here) when compared to unaffected littermates (I) from unaffected BA1 (J) to clearly dysmorphic (K). All arrowheads indicate BA1.
FIG. 5.
Effects of ectopic BMP4 on intact mandibular explants. As diagrammed in panel A, first branchial arches from E10.5 embryos were removed and cultured 20 -24 h (E10.5 ϩ 1D) on culture inserts over tissue-culture medium, conditions under which the tissues thrive. Relative endogenous domains of Fgf8 and Bmp4 in wild-type BA1 are diagrammed on one half-mandible. Results are quantified in Table  1 and illustrated in panels B-I. Beads (white asterisks in all panels) coated with recombinant BMP4 protein (B, D, E, G, H, J) or control medium (C, F, I) are placed on BA1 explants. BMP4 beads were able to induce expression of the putative transcriptional target Msx1 (B). Ectopic BMP4 represses the expression of Pax9 (E) and Fgf8 (H); compare expression near bead to untreated side of explant. Control beads have none of the effects shown by BMP4 (C, F, I ). Additionally, BMP4 induces the expression of its antagonists noggin (D) and chordin (G, J). Insets in G are a closer view of the same bead (a) and a separate bead which did not induce Chd (b) showing the relatively weak signal is not simply an effect of bead placement and perturbation of BA1 tissue. Some explants with Chd expression induced by BMP4 beads in E10.5 explants show weak lateral expression, as in this example. Additionally, Chd induction is more robust in E11.5 explants (2:7) and medial areas of weak expression are noted. Location of beads did not affect any induction. (Panel A adapted from Larsen, 1997) .  FIG. 6 . Msx1 and noggin are early responses to increased BMP4, while Fgf8 is later. Application of BMP4 protein (beads highlighted by white asterisks in all panels) for 1 h (A, C, E) in mandibular explant culture induces Msx1 (A) and noggin (B) but doesn't repress Fgf8 (E). At 3 h of BMP4 co-culture, induction of Msx1 (B) and noggin (D) is more robust and Fgf8 (F) repression is now clear. (Fig. 8B,C) as well as asymmetric cell death (Fig. 8D) likely result in the great variability of mandibular phenotypes in double mutants. The pattern of cell death observed resembles that observed in the absence of Fgf8 in the first branchial arch (Trumpp et al., 1999) , strongly suggesting that the lack of this growth factor contributes to the defects observed.
We also determined an apoptotic index and a proliferative index using thin sections. We detected apoptosing cells in thin sections using TUNEL analysis and simultaneously detected cells in metaphase with an antibody directed against phosphorylated histone (Fig. 8G,H) . Apoptosing and proliferating cells were counted in four separate fields of first branchial arch mesenchyme in one pair of littermates. Similar results were observed in other pairs of littermates. Of 904 wildtype cells counted, 7.1% were in metaphase and 0.22% were TUNEL-positive. Of 911 Chd;Nog double null cells counted, 6.5% were in metaphase, and 11.0% were TUNEL-positive. From this, we conclude that proliferation is essentially unchanged, and apoptosis is dramatically increased nearly 50-fold in the mesenchyme of the first branchial arch in Chd;Nog double null embryos.
In addition to hypoplasia of the first branchial arch, some mutants have BA1 lobes abnormally fused at the midline. These mutants have increased levels of NBS-positive cells in the midline at E9.5, but not throughout the mesenchyme (Fig. 8F) . This alternate pattern of cell death suggests that the mechanics of this class of mutant phenotypes differs substantially from Fgf8 mutants, and may result from an early deletion of the midline (R.M.A., J.K., unpublished observations).
DISCUSSION
We have determined a requirement for two dedicated BMP antagonists, Chordin and Noggin, in normal mandibular development in the mouse. Both Chd and Nog are expressed in the mandibular prominence during patterning and in the pharyngeal region adjacent to the initial BA1 swellings. Nog Ϫ/Ϫ mice have modestly dysmorphic mandibles, whereas Chd Ϫ/Ϫ mice have overtly normal mandibles. Neither appears to have a defect in tooth development. However, Chd and Nog are functionally redundant in promoting mandibular outgrowth, in that complex heterozygotes (Chd Ϫ/Ϫ ;Nog ϩ/Ϫ ) and double null mutants (Chd Ϫ/Ϫ ;Nog Ϫ/Ϫ ) have a spectrum of mandibular hypoplasia culminating in almost total agnathia. Although mandibular prominences grow in part by streaming in of neural crest cells from the pharyngeal region, neural crest specification and migration into BA1was normal even in strongly affected Chd;Nog double mutants. We also detected no significant decrease in proliferation of cells during outgrowth. To determine what alternative explanation(s) might account for the mandibular truncations we observe, we used an explant system to model the effects of excessive BMP4 on early mandibular tissue. Ectopic BMP4 induced both Chd and Nog expression, and repressed Fgf8 expression in the cultured explants. Double null mutants show greatly increased levels of Nog transcription and most show a reduction in Fgf8 expression, as does a smaller proportion of the complex heterozygotes. We suggest that ectopic BMP signaling in these mutants causes a downregulation of Fgf8, which serves as a trophic factor for cells populating BA1 (Trumpp et al., 1999) . Double mutants show increased cell death during early mandibular outgrowth very similar to that observed when Fgf8 is specifically ablated in BA1 (Trumpp et al., 1999) . Ectopic BMP activity may also 
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Note. Mandibular explants from E10.5 embryos were cultured with recombinant protein treated beads for 20 -24 h. Explants were scored for repression or induction of the relevant marker. Those displaying a change were classified as showing mild (ϩ) or strong (ϩϩ) effects.
TABLE 3
Ectopic BMP4 Has Rapid Effects on Targets in Mandibular Explants
Marker 6h 3h 1h
Note. Explants treated with recombinant BMP4 were fixed at 1, 3, and 6 h after bead addition and assayed by whole mount in situ hybridization for target gene expression. Data is shown as the number of repressive or inductive events as a portion of the total experiments.
increase apoptosis independently, in that it promotes apoptosis in craniofacial neural crest (Graham et al., 1996) . Thus, the BMP antagonists Chordin and Noggin are essential for mandibular development in the mouse, acting to maintain a proper balance of signaling and trophic factors during outgrowth.
Expression and Function of Chordin and Noggin in the Mandibular Arch Are Redundant
The BA1 phenotypes we have observed in Chd;Nog mutants have been apparent as early as E9.0, which is when mandibular outgrowth begins. The mandibular buds begin as paired swellings ventrolateral to the pharynx, and grow as cranial NC cells migrate through the pharynx and into the bud to form the mesenchymal core of the mandibular prominence. During this time, Chd and Nog are both expressed in the pharyngeal endoderm and at lower levels in the pharyngeal ectoderm. Nog is also expressed in migrating NC cells as they stream into the bud. Fgf8 is also expressed in the pharyngeal endoderm and ectoderm (Crossley and Martin, 1995) , where it provides a critical trophic signal for survival of NC cells as they migrate into the mandibular region (Trumpp et al., 1999) . The earliest defect we have detected is marked downregulation of pharyngeal Fgf8 expression at E8.5. Because Chordin and Noggin are both dedicated BMP antagonists, embryos carrying null alleles presumably exhibit localized ectopic BMP activity. Our explant experiments show that in the mouse mandibular bud, BMP4 beads downregulate Fgf8 expression. The probable increase in peripharyngeal activity of BMPs might therefore be sufficient in some cases to downregulate Fgf8 expression and consequently lead to increased cell death of migrating NC cells (Fig. 9) . Indeed, we detected increased cell death in the mandibular process at E9.0 -9.5 in a distribution very similar to that observed in embryos lacking Fgf8 function in the pharyngeal/mandibular region (Trumpp et al., 1999) . Recent work in chick embryos provides strong support for this model. Ectopic BMP at the site of BA1 outgrowth results in down-regulation of Fgf8 expression and truncation of mandibular outgrowth (Shigetani et al., 2000) .
We suggest that the variability of the mandibular hypoplasia observed when Chordin and Noggin are reduced or absent is a result of variable down-regulation of Fgf8. Consistent with the range in mandibular truncations, we see a range in the extent of cell death in the elongating buds. Interestingly, these defects are sometimes asymmetric, occasionally resulting in one normal "half-mandible" and one side where the jaw is completely absent (Fig. 3H) . This asymmetry may be due to a stochastic difference between the mandibular buds in BMP signaling prior to their fusion. We have seen mutant embryos in which the expression of Fgf8 differs between the two premandibular areas (Fig.  7O,P) , and corresponding asymmetric patterns of cell death in the nascent mandibular buds (Fig. 8D) . We speculate that such embryos would go on to have asymmetric mandibular truncations. Similarly asymmetric phenotypes are also observed in certain human craniofacial syndromes (Escobar, 1993) , further implying that abnormal BMP or FGF activity might underlie some such human malformations.
Despite expression of Chd and Nog expression in the oral epithelium, and evidence that BMP signaling must be properly regulated for normal tooth development (Tucker et al., 1998) , none of the mutant classes reveal any overt defects in tooth position, shape or morphology. Possible tooth phenotypes in a Chd Ϫ/Ϫ ;Nog Ϫ/Ϫ double mutant may be present, but can only be revealed in a tissue specific knockout due to early lethality. Alternatively, they may have no critical role in tooth development or their function may be redundant with additional BMP antagonists. Mice mutant for follistatin have tooth defects (Matzuk et al., 1995) , and Follistatin is able to antagonize BMPs as well as other TGF␤ ligands (Fainsod et al., 1997; reviewed in Harland and Gerhart, 1997) . Another nonspecific BMP antagonist, DAN, is also expressed in BA1 (Stanley et al., 1998) , but loss of DAN alone or when Nog is reduced causes no BA1 phenotype (Dionne et al., 2001) .
We also found that Nog is expressed in the neural crest populating BA1 during outgrowth, and later in the neuralcrest derived Meckel's cartilage at the core of the mandible. Meckel's cartilage becomes ensheathed by bone during skeletogenesis, and it may be that Nog expression therein regulates the process of ossification. This may explain the thickened bony tissue of Nog Ϫ/Ϫ mandibles, since loss of the antagonist might result in local overactivity of BMP, in turn causing excess bone production.
An Explant System Reveals Novel BMP Interactions in Branchial Arch Tissue
To model the effects of the increase in BMP signaling expected to occur in the absence of these BMP antagonists, we applied beads soaked in recombinant BMP4 to cultured E10.5 mandibular explants. We used BMP4 in our experiments as a means of increasing the activation of BMP signal transduction, but do not mean to imply that it is the only relevant BMP in vivo. Chordin and Noggin together antagonize BMP4, BMP2, and BMP7 (Harland and Gerhart, 1997) , and probably other, untested BMPs as well. Other studies have shown these BMPs to be largely interchangeable in the context of explant and embryo manipulations, activation of signaling pathways, and other functional assays (Massugue and Chen, 2000; Hogan, 1996) . As previously discussed, several BMPs are expressed during early mandibular development and have dramatic effects in BA1 manipulation experiments (see Introduction). In vivo, BMP2, 4, and 7 are all potentially regulated by BMP antagonists during mandibular development.
Ectopic BMP4 induced the expression of its own antagonists, Chd and Nog, as well as previously established transcriptional targets such as Msx1. The induction of Nog was very rapid, robust within an hour, presumably before a round of transcription, translation and processing of an intermediate protein could be completed. Thus, we suggest that this induction does not depend on the prior upregulation of Msx1, but rather occurs via activation of some pre-existent regulatory mechanism. Indeed, BMP4 does not require Msx1 (Chen et al., 1996) to induce one of its known targets, Lef1 (Kratochwil et al., 1996) in BA1 explants. While Nog is expressed in the oral epithelium along the entire proximo-distal axis (Fig. 1) , Bmp4 is restricted to the most distal tissue. Other BMPs may be the endogenous upstream signal for Nog induction in the embryo. Indeed, Bmp7 is expressed throughout the oral epithelium in a pattern very similar to that of Nog (Solloway and Robertson, 1999) . This upregulation of Nog and Chd by excessive BMP could reflect a negative feedback mechanism to keep functional BMP levels in check, probably able to compensate very quickly for excessive BMP.
A key finding of our mandibular explant experiments is that BMP4 beads repressed Fgf8 expression. In many developmental contexts BMPs and FGFs have antagonistic interactions; some of these may be due to a direct repression of Fgf expression by BMP. There is some precedent for this: ectopic BMP4 represses Fgf4 expression in the chicken feather bud (Jung et al., 1998) , and may do so in limb bud formation (Pizette and Niswander, 1999) . Consistent with our results, ectopic BMP beads applied to chick pharyngeal ectoderm downregulated Fgf8 in vivo (Shigetani et al., 2000) . Fgf8 and Bmp4 may have slightly overlapping domains of expression in the oral epithelium. We suggest that Fgf8 expression is protected from the effects of BMP4 by the presence of BMP antagonist such as Noggin and Chordin.
Expression of BA1 Markers in Mice Mutant for BMP Antagonists
To test some of the hypotheses generated by the mandibular explant work, we looked at the expression patterns of BA1 markers in mice mutant for the BMP antagonists. Since we found that BMP upregulates its antagonists in explants, we assessed Nog expression in Nog Ϫ/Ϫ mutants using both the lacZ transgene and WMISH. We find that Nog is indeed expressed more highly at both E9.5 and E10.5 in all domains observed, including BA1. This upregulation was much stronger in embryos lacking both Chd and Nog, in which case there is presumably a higher level of ectopic BMP activity. Upregulation of Nog transcription by ectopic BMP has been demonstrated previously both in cell culture (Gazzerro et al., 1998; Kameda et al., 1999; Nifuji and Noda, 1999) and in the chick digit (Merino et al., 1998 E9.5 (compare F, G) . Panels H-K show isolated BA1 from E10.5 embryos from the ventral aspect. Bmp4 expression is more intense in Nog Ϫ/Ϫ mutants (H) compared to wild-type (WT) littermates (I). Fgf8, however, does not seem to be different between Nog Ϫ/Ϫ (J) and wild-type embryos (K). AP2␣ expression indicates neural crest does properly migrate to BA1 in both wild-type (L) and mutant (M) embryos. Analysis of Chd Ϫ/Ϫ ;Nog Ϫ/Ϫ double null mutant embryos at E8.5 sometimes reveals an asymmetric decrease in BA1 Fgf8 expression (O, P; BA1 domain indicated by white arrowheads). Both the right (O) and left (P) side of a double mutant and the right side of a wild-type (N) littermate are shown; note the more severe reduction in P. Black markings in N, P indicate direction of heart looping. Looping is to the right in N and to the left in P, reflecting abnormalities in left-right patterning seen in the double mutants (Bachiller et al., 2000) . fb, forebrain; he, heart. much faster than that observed in the chicken digit (Merino et al., 1998) . We also observed an increase in BMP4 transcription in the branchial arches of Nog Ϫ/Ϫ embryos, further suggesting that the molecular feedback circuitry governing net BMP4 activity is complex.
While ectopic BMP4 can repress Fgf8 in mandibular explants, Fgf8 is only mildly repressed if at all in BA1 of Nog Ϫ/Ϫ embryos. However, in Chd Ϫ/Ϫ ;Nog Ϫ/Ϫ embryos, Fgf8 is frequently severely reduced or absent in the branchial arches. Less frequently, similar Fgf8 downregulation was observed in the complex heterozygote. These data suggest that the BMP antagonists function redundantly in vivo to limit the repressive effect of Bmp4 on Fgf8 expression, consistent with the spatiotemporal expression patterns of Bmp4, Fgf8, and Nog during early BA1 development.
Although we find some evidence of increased BMP activity in Nog and Chd;Nog mutants, we have found no evidence for upregulation of the BMP target Msx1 in anterior tissues of any of the mutant classes (data not shown; R.M.A., unpublished results). This further suggests that, in vivo, at least some effects of increased BMP activity on early BA1 outgrowth are not mediated by increased transcription of Msx1. However, BMP7 does not efficiently increase Msx1 expression (Furuta et al., 1997) and based on expression is perhaps the best candidate for the endogenous BMP effecting Fgf8 regulation in the outgrowth stage.
Integrating Chordin, Noggin, BMPs, and Fgf8 in Mandibular Outgrowth
Our observations allow us to add to the current view of branchial arch outgrowth and patterning. Fgf8 is required for NC survival during population of BA1 (Trumpp et al., 1999) and BMPs can prevent outgrowth (Shigetani et al., 2000; see above) . We suggest that, in vivo, BMPs in the oral epithelium of BA1 and Fgf8 in the pharyngeal endoderm and BA1 oral epithelium send two competing signals to the NC populating BA1 during outgrowth (Fig. 9A) : an apoptotic BMP signal and a trophic FGF signal. The BMP signal is partially negated by Noggin and Chordin from the pharyngeal ectoderm and endoderm, and perhaps by Noggin alone from the migrating NC, to help provide a suitable environment for NC survival (Fig. 9B) . However, in the absence of these two BMP antagonists (Fig. 9C) , increased BMP activity leads to decreased Fgf8 expression, both decreasing the survival signal mediated by Fgf8 (Trumpp et al., 1999) and perhaps increasing the apoptosis promoted by BMP4 (Graham et al., 1996) . The net result is an incomplete and variably penetrant ablation of NC fated to populate BA1.
Although we hypothesize that the outgrowth defects we observe in Chd;Nog mutants results in large part from Fgf8 downregulation, there is an additional defect resulting from the loss of these BMP antagonists relative to the ablation of Fgf8 in BA1. When Chordin and Noggin are decreased, the mandibular hypoplasia includes a loss of distal elements. Absence of Fgf8 results in a similar phenotype except that distal elements persist (Trumpp et al., 1999) . Because Bmp4 is expressed in this distal tissue (Jones et al., 1991; Neubuser et al., 1997) and because excessive BMP4 promotes apoptosis in several contexts (e.g., Graham et al., 1996; Gomes and Kessler, 2001; Trousse et al., 2001) , it may die if too much BMP4 is produced. Such might be expected in Chd;Nog mutants, since they have much decreased levels of BMP antagonism. Indeed, we detected a high level of ectopic apoptosis in this region in the double mutants (Fig.  8E,F) . There seems to be a critical period for BMP regulation of NC survival as BMP added to later stages of chick development result in skeletal malformations, not cell death (Shigetani et al., 2000) . We suggest this reflects a difference in regulation of the initial outgrowth stage of BA1 development and later patterning events, though similar regulatory factors may be involved.
BMP Signaling Is Sensitive to Dosage in Several Developmental Contexts
The only known role of the Chordin and Noggin proteins is to antagonize BMP and BMP-like proteins such that they cannot bind and activate their receptors (reviewed by Sasai and De Robertis, 1997) . Known targets include BMP2 and 4 for Chordin (Piccolo et al., 1996), and BMP2,4, and 7 (Zimmermann et al., 1996) , GDF6 (a.k.a. BMP13; Chang and Hemmati-Brivanlou, 1999 ) and GDF5, another BMP relative, (Merino et al., 1999) for Noggin. Given our observation that BMP can upregulate Chd and Nog in BA1, it may upregulate other BMP antagonists as well. We have noted previously that BMP levels are subject to several levels of feedback regulation. Phenotypes would result only when the total level of BMP antagonism falls below some threshold, and some deleterious event such as Fgf8 repression occurs. As discussed earlier, the asymmetric phenotypes we observe suggest that even within a single embryo, BMP levels can differ significantly between the two mandibular prominences.
These findings suggest that BMP signal transduction is very tightly regulated, with small changes in signal transduction potentially resulting in dramatically different physiological outcomes. In addition to the variable mandibular phenotypes we observe here among mice of the same genotype and genetic background, other developmental models show high sensitivity to BMP dosage. Mice heterozygous for Bmp4 on a C57Bl/6 background have an incompletely penetrant craniofacial phenotype, although the affected tissues are not derived from BA1 (Dunn et al., 1997) . Mice heterozygous for the short-ear (Bmp5) mutation have a skeletal phenotype (Green, 1968; Kingsley et al., 1992) . Dosage effects of Dlx homeobox genes, a target of BMP signaling (Luo et al., 2001 ) have also been demonstrated in craniofacial development . Similarly, Drosophila embryos lacking one copy of the Bmp4 homologue, decapentaplegic, show a defect in dorsal-ventral patterning in the absence of maternal product (Irish and Gelbart, 1987) . This type of balance would certainly be well served by a system where the active agent (BMP) engages in a functional negative feedback loop by inducing the expression of directly antagonistic molecules (Noggin and Chordin). All of these findings support the hypothesis that tightly regulated BMP activity is very important for proper embryonic development, including mandibular outgrowth.
